News search

E.g., 20/08/2025
E.g., 20/08/2025
Foto
Research
19 Nov 2018

The scientific event, which took place in Madrid, brought together more than 100 researchers from different fields of cardiovascular biology

From left to right: David Sancho, Carlos del Fresno, Paula Saz, and Sarai Martínez Cano.
Research
19 Oct 2018

CNIC researchers have discovered a new inflammatory control mechanism that paves the way to controlling injury generated during the immune response

Prof. Eldad Tzahor
Research
18 Oct 2018

Professor Eldad Tzahor, Director of the Cellular and Molecular Biology Laboratory at the Weizmann Institute of Science, in Rehovo (Israel).


About the CNIC
1 Oct 2018

The Fundación AstraZeneca young researcher awards were created to give scientists the opportunities they deserve

About the CNIC
10 May 2018
De izda. a dcha.: José Antonio Enriquez, María del Mar Muñoz, Fátima Sánchez-Cabo, Luis Jesús Jiménez-Borreguero, Rocío Nieto-Arellano, Andrés González-Guerra, Carlos Torroja, José María Castellanos, y Concepción Jiménez.
Research
3 Apr 2018

The study is published in Science Translational Medicine and was conducted by researchers at the Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC)

Research
3 Apr 2018

ReDIB is composed of two nodes, located at the Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC) in Madrid and the Centro de Investigación Cooperativa en Biomateriales (CIC biomaGUNE) in San Sebastián

About the CNIC
21 Mar 2018

The OTRIs are intermediaries in the science-technology-enterprise system, and their mission is to boost relations among the agents of the system

Training
20 Mar 2018

INPhINIT is a PhD scholarship program Promoted by the Social Project “Obra Social ‘la Caixa’” and designed to integrate young international researchers in the best Spanish research centers, in the fields of technology, engineering, physics, mathematics, health sciences and life sciences

Foto
Research
5 Mar 2018

Investigadores del CNIC, del CIBERCV y de la Universidad de Oviedo han creado el primer modelo de ratón con aterosclerosis acelerada por la proteína progerina